Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Onyx Pharma shares rise as analyst says sales of myeloma drug could reach $1B a year by 2016
Onyx Pharma shares rise as analyst says sales of myeloma drug could reach $1B a year by 2016
Onyx Pharma shares rise as analyst says sales of myeloma drug could reach $1B a year by 2016
Submitted by
admin
on May 25, 2012 - 11:18am
Source:
Yahoo/AP
News Tags:
Onyx
myeloma
Kyprolis
Headline:
Onyx Pharma shares rise as analyst says sales of myeloma drug could reach $1B a year by 2016
Do Not Allow Advertisers to Use My Personal information
